Covid vaccine: German ambassador to UK rejects ministers’ claims Pfizer approval is win for Britain
‘I really don’t think this is a national story,’ says envoy – after government claims Britain is ‘leading humanity’s charge’
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The German ambassador to the UK has criticised Boris Johnson’s government for claiming the approval of the vaccine developed by Pfizer and BioNTec was a huge “national” win for Britain.
Andreas Michaelis said British ministers were downplaying the importance of “European and transatlantic” work to get the vaccine ready for roll-out.
“Why is it so difficult to recognise this important step forward as a great international effort and success? I really don’t think this is a national story,” he tweeted — hailing the work of German company BioNTec.
Health secretary Matt Hancock said on Wednesday that he was “very proud” that the UK had become the first place in the world to have a clinically authorised coronavirus vaccine.
“I’m obviously absolutely thrilled with the news. I’m very proud that the UK is the first place in the world to have a clinically authorised vaccine ready to go,” he said.
Business secretary Alok Sharma also hailed the breakthrough — and claimed the UK had “led humanity’s charge” against the virus.
“The UK was the first country to sign a deal with Pfizer/BioNTech — now we will be the first to deploy their vaccine,” he said. “In years to come, we will remember this moment as the day the UK led humanity’s charge against this disease.”
Mr Hancock also claimed Brexit had helped “speed up” the vaccine approval process by freeing the UK from European regulatory processes.
“Whilst until earlier this year we were in the European Medicines Agency (EMA), because of Brexit we’ve been able to make a decision to do this based on the UK regulator, a world-class regulator, and not go at the pace of the Europeans, who are moving a little bit more slowly,” he told Times Radio.
“We do all the same safety checks and the same processes, but we have been able to speed up how they’re done because of Brexit.”
However, Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), which approved the vaccine, contradicted Mr Hancock’s claims.
Speaking at a Downing Street press conference, Dr Raine made clear that the MHRA were working under EU rules and procedures and were not able to go any faster because of Brexit.
Professor Sir Munir Pirmohamed, of the Commission on Human Medicines advisory panel, said approval of the vaccine was an “historic moment”.
He told the government press conference: “We are in the midst of a once-in-a-century pandemic and I think this is a historic moment … This will help to save lives.”
Meanwhile, Mr Johnson said the approval by the MHRA was “fantastic” news, tweeting: “It’s the protection of vaccines that will ultimately allow us to reclaim our lives and get the economy moving again.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments